Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandros P Papadopoulos

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Middle East African Journal of Ophthalmology|March 27, 2014
Current management of presbyopiaPandelis A Papadopoulos, Alexandros P Papadopoulos
Expert Opinion on Drug Safety|September 7, 2023
COMfort Eye Trial (COMET) results - a non-inferiority, randomized, investigator-masked, two-parallel group, phase III clinical trial, to evaluate the efficacy and safety of a preservative free formulation of latanoprost versus a reference drug (Xalatan®) in patients with primary open-angle glaucoma (POAG) or ocular hypertension (OHT)Stylianos Kandarakis, Alexandros P Papadopoulos, Georgios Roussopoulos, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Middle East African Journal of Ophthalmology|March 27, 2014
Current management of presbyopiaPandelis A Papadopoulos, Alexandros P Papadopoulos
Expert Opinion on Drug Safety|September 7, 2023
COMfort Eye Trial (COMET) results - a non-inferiority, randomized, investigator-masked, two-parallel group, phase III clinical trial, to evaluate the efficacy and safety of a preservative free formulation of latanoprost versus a reference drug (Xalatan®) in patients with primary open-angle glaucoma (POAG) or ocular hypertension (OHT)Stylianos Kandarakis, Alexandros P Papadopoulos, Georgios Roussopoulos, et al.
Pageof 1